Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Achenbach

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
JAMA|September 8, 2023
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early ChildhoodMarija Lugar, Anne Eugster, Peter Achenbach, et al.
Diabetologia|June 17, 2023
Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestationSandra Hummel, Johanna Carl, Nadine Friedl, et al.
Diabetologia|January 30, 2021
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trialRobin Assfalg, Jan Knoop, Kristi L Hoffman, et al.
BMJ Open|January 3, 2025
EDENT1FI Master Protocol for screening of presymptomatic early-stage type 1 diabetes in children and adolescentsLuisa Hoffmann, Mirjam Kohls, Stefanie Arnolds, et al.
Diabetes Care|January 21, 2026
Effect of High-Dose Oral Insulin in Children With Stage 1 Type 1 Diabetes: The Fr1da Insulin Intervention Randomized Controlled TrialAnette-Gabriele Ziegler, Ali Albeer, Stefanie Arnolds, et al.
Med (New York, N.Y.)|November 9, 2020
A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in ChildrenMarkus Hippich, Lisa Holthaus, Robin Assfalg, et al.
Diabetes|February 25, 2014
A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetesRicardo C Ferreira, Hui Guo, Richard M R Coulson, et al.
Contemporary Clinical Trials Communications|September 11, 2018
Recruiting young pre-symptomatic children for a clinical trial in type 1 diabetes: Insights from the Fr1da insulin intervention studyKerstin Kick, Robin Assfalg, Susanne Aydin, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 2026
Determinants of Infant Participation and Non-Participation in Primary Prevention TrialsFranziska Wörl, Peter Achenbach, Ezio Bonifacio, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 6, 2024
[Early Detection Of Type 1 Diabetes By Islet Autoantibody Screening: A Position Paper Of The Fr1daplex Project Leaders And Training Centres, Bvkj Bavaria And Paednetz (Registered) Bavaria]Peter Achenbach, Reinhard Berner, Ezio Bonifacio, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
JAMA|September 8, 2023
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early ChildhoodMarija Lugar, Anne Eugster, Peter Achenbach, et al.
Diabetologia|June 17, 2023
Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestationSandra Hummel, Johanna Carl, Nadine Friedl, et al.
Diabetologia|January 30, 2021
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trialRobin Assfalg, Jan Knoop, Kristi L Hoffman, et al.
BMJ Open|January 3, 2025
EDENT1FI Master Protocol for screening of presymptomatic early-stage type 1 diabetes in children and adolescentsLuisa Hoffmann, Mirjam Kohls, Stefanie Arnolds, et al.
Diabetes Care|January 21, 2026
Effect of High-Dose Oral Insulin in Children With Stage 1 Type 1 Diabetes: The Fr1da Insulin Intervention Randomized Controlled TrialAnette-Gabriele Ziegler, Ali Albeer, Stefanie Arnolds, et al.
Med (New York, N.Y.)|November 9, 2020
A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in ChildrenMarkus Hippich, Lisa Holthaus, Robin Assfalg, et al.
Diabetes|February 25, 2014
A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetesRicardo C Ferreira, Hui Guo, Richard M R Coulson, et al.
Contemporary Clinical Trials Communications|September 11, 2018
Recruiting young pre-symptomatic children for a clinical trial in type 1 diabetes: Insights from the Fr1da insulin intervention studyKerstin Kick, Robin Assfalg, Susanne Aydin, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 2026
Determinants of Infant Participation and Non-Participation in Primary Prevention TrialsFranziska Wörl, Peter Achenbach, Ezio Bonifacio, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 6, 2024
[Early Detection Of Type 1 Diabetes By Islet Autoantibody Screening: A Position Paper Of The Fr1daplex Project Leaders And Training Centres, Bvkj Bavaria And Paednetz (Registered) Bavaria]Peter Achenbach, Reinhard Berner, Ezio Bonifacio, et al.
Pageof 11